Phase I–II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I–II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities

Published:2003-06 Issue:3 Volume:13 Page:293-297
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Rossi C R,Lejeune F J,Pontes L,Foletto M,De Salvo G L,Pilati P L,Mocellin S,Ribeiro M,Lopes M,Lise M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference18 articles.

1. Chemotherapy of Cancer

2. Management of cutaneous melanoma M0: state of the art and trends

3. Hyperthermic regional perfusion for melanoma and sarcoma of the limbs

4. Isolated limb perfusion in locally advanced cutaneous melanoma

5. Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fotemustine for the treatment of melanoma;Expert Opinion on Pharmacotherapy;2011-11-14

2. Isolated Limb Perfusion and Isolated Limb Infusion for Malignant Lesions of the Extremities;Current Problems in Surgery;2011-06

3. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma;International Journal of Hyperthermia;2008-01

4. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence;European Journal of Surgical Oncology (EJSO);2004-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3